Ryan Wereski

1.7k total citations
27 papers, 336 citations indexed

About

Ryan Wereski is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Ryan Wereski has authored 27 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 15 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Surgery. Recurrent topics in Ryan Wereski's work include Acute Myocardial Infarction Research (21 papers), Cardiac Imaging and Diagnostics (15 papers) and Coronary Interventions and Diagnostics (11 papers). Ryan Wereski is often cited by papers focused on Acute Myocardial Infarction Research (21 papers), Cardiac Imaging and Diagnostics (15 papers) and Coronary Interventions and Diagnostics (11 papers). Ryan Wereski collaborates with scholars based in United Kingdom, United States and Sweden. Ryan Wereski's co-authors include Nicholas L. Mills, Amy V. Ferry, Andrew R. Chapman, Fiona E. Strachan, Caelan Taggart, Anda Bularga, David J. Lowe, Dorien M. Kimenai, Kuan Ken Lee and Dimitrios Doudesis and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Ryan Wereski

24 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan Wereski United Kingdom 11 188 141 87 70 60 27 336
Phillip Freeman Denmark 13 257 1.4× 63 0.4× 95 1.1× 105 1.5× 9 0.1× 49 501
Juan Pablo Costabel Argentina 13 330 1.8× 103 0.7× 72 0.8× 26 0.4× 7 0.1× 98 432
Jay Khambhati United States 10 116 0.6× 24 0.2× 57 0.7× 22 0.3× 18 0.3× 21 325
Hesham K. Abdelaziz United Kingdom 9 132 0.7× 21 0.1× 63 0.7× 27 0.4× 37 0.6× 27 249
Soon Yeng Soo Hoo Australia 8 280 1.5× 69 0.5× 65 0.7× 19 0.3× 10 0.2× 15 364
Emanuele Capasso Italy 11 34 0.2× 25 0.2× 90 1.0× 51 0.7× 36 0.6× 49 317
L.T. Burgers Netherlands 6 75 0.4× 81 0.6× 66 0.8× 35 0.5× 8 0.1× 10 337
Awais Amjad Malik Pakistan 10 51 0.3× 23 0.2× 138 1.6× 39 0.6× 11 0.2× 45 276
Ahmet Yanık Türkiye 10 147 0.8× 43 0.3× 40 0.5× 8 0.1× 12 0.2× 25 285
S Fleming Ireland 9 217 1.2× 61 0.4× 42 0.5× 21 0.3× 17 0.3× 13 288

Countries citing papers authored by Ryan Wereski

Since Specialization
Citations

This map shows the geographic impact of Ryan Wereski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Wereski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Wereski more than expected).

Fields of papers citing papers by Ryan Wereski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Wereski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Wereski. The network helps show where Ryan Wereski may publish in the future.

Co-authorship network of co-authors of Ryan Wereski

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Wereski. A scholar is included among the top collaborators of Ryan Wereski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Wereski. Ryan Wereski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Ziwen, Dimitrios Doudesis, Ryan Wereski, et al.. (2025). Safety of Using Risk Stratification Along With High-Sensitivity Cardiac Troponin in the Emergency Department. Journal of the American College of Cardiology. 86(19). 1738–1748.
2.
Williams, Michelle C., Ryan Wereski, Christopher Tuck, et al.. (2025). Coronary CT angiography-guided management of patients with stable chest pain: 10-year outcomes from the SCOT-HEART randomised controlled trial in Scotland. The Lancet. 405(10475). 329–337. 10 indexed citations
3.
Boeddinghaus, Jasper, Anda Bularga, Caelan Taggart, et al.. (2024). Implications of a new clinical classification of acute myocardial infarction. European Heart Journal. 45(Supplement_1).
4.
Taggart, Caelan, Andreas Roos, Atul Anand, et al.. (2024). Application of the Universal Definition of Myocardial Infarction in Clinical Practice in Scotland and Sweden. JAMA Network Open. 7(4). e245853–e245853. 4 indexed citations
5.
Cholewa-Waclaw, Justyna, Ryan Wereski, Stefan Veizades, et al.. (2024). COVID-19 plasma induces subcellular remodelling within the pulmonary microvascular endothelium. Vascular Pharmacology. 154. 107277–107277. 1 indexed citations
6.
Lee, Kuan Ken, David J. Lowe, Rachel O’Brien, et al.. (2023). Troponin in acute chest pain to risk stratify and guide effective use of computed tomography coronary angiography (TARGET-CTCA): a randomised controlled trial. Trials. 24(1). 402–402. 3 indexed citations
7.
Jaffe, Allan S., Richard Body, Nicholas L. Mills, et al.. (2023). Single Troponin Measurement to Rule Out Myocardial Infarction. Journal of the American College of Cardiology. 82(1). 60–69. 14 indexed citations
8.
Meah, Mohammed N., Ryan Wereski, Anda Bularga, et al.. (2023). Coronary low-attenuation plaque and high-sensitivity cardiac troponin. Heart. 109(9). 702–709. 11 indexed citations
9.
Wereski, Ryan, Philip D Adamson, Caelan Taggart, et al.. (2023). High-Sensitivity Cardiac Troponin for Risk Assessment in Patients With Chronic Coronary Artery Disease. Journal of the American College of Cardiology. 82(6). 473–485. 8 indexed citations
11.
Taggart, Caelan, Amy V. Ferry, Andrew R. Chapman, et al.. (2023). Consensus on the diagnosis and management of patients with type 2 myocardial infarction: an international Delphi study. European Heart Journal. 44(Supplement_2). 2 indexed citations
12.
Lowry, Matthew T.H., Dimitrios Doudesis, Ryan Wereski, et al.. (2022). Influence of Age on the Diagnosis of Myocardial Infarction. Circulation. 146(15). 1135–1148. 20 indexed citations
13.
Meah, Mohammed N., Anda Bularga, Evangelos Tzolos, et al.. (2022). Distinguishing Type 1 from Type 2 Myocardial Infarction by Using CT Coronary Angiography. Radiology Cardiothoracic Imaging. 4(5). e220081–e220081. 3 indexed citations
14.
Wereski, Ryan, Dorien M. Kimenai, Anda Bularga, et al.. (2021). Risk factors for type 1 and type 2 myocardial infarction. European Heart Journal. 43(2). 127–135. 50 indexed citations
15.
Kimenai, Dorien M., Bertil Lindahl, Andrew R. Chapman, et al.. (2021). Sex differences in investigations and outcomes among patients with type 2 myocardial infarction. Heart. 107(18). 1480–1486. 10 indexed citations
16.
Taggart, Caelan, Ryan Wereski, Nicholas L. Mills, & Andrew R. Chapman. (2021). Diagnosis, Investigation and Management of Patients with Acute and Chronic Myocardial Injury. Journal of Clinical Medicine. 10(11). 2331–2331. 12 indexed citations
17.
Wereski, Ryan, Dorien M. Kimenai, Caelan Taggart, et al.. (2021). Cardiac Troponin Thresholds and Kinetics to Differentiate Myocardial Injury and Myocardial Infarction. Circulation. 144(7). 528–538. 47 indexed citations
18.
Lee, Kuan Ken, Anda Bularga, Rachel O’Brien, et al.. (2021). Troponin-Guided Coronary Computed Tomographic Angiography After Exclusion of Myocardial Infarction. Journal of the American College of Cardiology. 78(14). 1407–1417. 25 indexed citations
19.
Ferry, Amy V., Ryan Wereski, Fiona E. Strachan, & Nicholas L. Mills. (2020). Predictors of UK healthcare worker burnout during the COVID-19 pandemic. QJM. 114(6). 374–380. 80 indexed citations
20.
Wereski, Ryan, Stephen W. Smith, Andrew R. Chapman, et al.. (2020). 21 High-sensitivity cardiac troponin concentrations at presentation in patients with st-segment elevation myocardial infarction. A15–A16. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026